BioLargo 2022 Annual Earnings Results Webcast and Conference Call on Monday, April 3, 2023 - 4:30 PM Eastern Time
WESTMINSTER, CA / ACCESSWIRE / March 29, 2023 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, will host an investor webcast and conference call on Monday, April 3, …
WESTMINSTER, CA / ACCESSWIRE / March 29, 2023 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, will host an investor webcast and conference call on Monday, April 3, 2023, at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for fiscal year ending December 31, 2022, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
Webcast Link: | |
Teleconference Domestic: |
888-506-0062 |
Teleconference International: Participant Access Code: |
973-528-0011 857043 |
To listen to a replay of the teleconference:
Teleconference Replay Expiration: |
Monday, April 17, 2023 |
Teleconference Replay Domestic: |
877-481-4010 |
Teleconference Replay International: |
919-882-2331 |
Replay Passcode: |
47877 |
The webcast replay and accompanying presentation materials will be made available for 90 days on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.
Lesen Sie auch
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and
wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product
offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.